The United States on Wednesday authorized Pfizer's anti-Covid pill for high-risk people aged 12 and up, as a surge of cases driven by the highly infectious Omicron variant threatened holiday plans and Americans struggled to find tests.
Pfizer said Tuesday that clinical trials confirmed its Covid pill, a new type of antiviral treatment that should withstand the mutations seen with Omicron, drastically reduced hospitalizations and deaths among at-risk people by almost 90 percent.
South Africa will next month start giving Pfizer booster shots against coronavirus, a health official said Friday, a day after the country reported a near-record high in daily cases
Germany's BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa.
Pfizer said Thursday it will sell 10 million Covid-19 treatment courses for Covid-19 to the US government for $5.3 billion, pending approval from regulators.
US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world's least wealthy countries.
Pfizer, BioNTech and Moderna are making combined profits of $65,000 every minute from their highly successful Covid-19 vaccines while the world's poorest countries remain largely unvaccinated, according to a new analysis.
Pfizer said Friday that a clinical trial of its pill to treat Covid-19 had shown it is highly effective.
Pfizer again lifted its 2021 profit and revenue outlook on Tuesday, bolstered by the latest surge in Covid-19 vaccinations, including regulatory approvals for boosters and shots for younger populations.
Applying our science and global resources to bring therapies to patients in a way that extend and significantly improve their lives is what we strive for as we set the standard for quality....
US drugmaker Pfizer said Thursday it has formally requested emergency use authorization for its Covid-19 vaccine in children age five to 11.
As part of efforts to celebrate Patients in Focus Week and Cancer Awareness Month, Pfizer has reiterated its commitment to churning out breakthroughs that change patients’ lives.